share_log

SVB Leerink Maintains Outperform on Replimune Group, Lowers Price Target to $30

SVB Leerink Maintains Outperform on Replimune Group, Lowers Price Target to $30

SVB Leerink維持Replimune集團的跑贏大盤,將目標股價下調至30美元
Benzinga Real-time News ·  2022/10/03 06:22

SVB Leerink analyst Jonathan Chang maintains Replimune Group (NASDAQ:REPL) with a Outperform and lowers the price target from $37 to $30.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論